Hospira Inc. has announced that its new non-opioid injection has been approved by the FDA. The drug, Dyloject, can be used alone, or in combination with non-opioid painkillers, the company said on Tuesday. Dyloject is an NSAID product. It does not constitute a replacement for opioids, but it can be administered within 15 seconds. According to Hospira, other injectable non-opioid painkillers depend upon dilution prior to administration, and typically require an infusion of 15 to 30 minutes for a full dose.
Read the full release from Reuters here.